|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
ӲƤ��,ϵͳ�� |
|
�������,���� |
|
���� |
| ��������������� | |
|
���� |
|
���¹� |
| PubMed | |
|
Article by |
|
Article by |
����ɨ�蹲�۽�������ϵͳ��ӲƤ����Ӧ��
����, ���¹�
ɽ����Ӫʤ��ʯ���������ҽԺƤ����, ����257034
ϵͳ��ӲƤ���ķ������Ʋ���,�������ѡ�����ɨ�蹲�۽������������ʶ������,�ɻ�ø߷���߷ֱ��ʡ��������ȵĶ�άͼ��,������ά�ؽ���ʾ���������ֵĿռ��ϵ�����ü���ɨ�蹲�۽�������ϵͳ��ӲƤ�����л��������۲�,��ʾ�������ڶ�ϵͳ��ӲƤ������Ϻ���Ч������
[2] Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am, 1996, 22:647-674.
[3] Leighton C. Drug treatment of scleroderma. Drugs, 2001,61:419-427.
[4] Benrud-Larson LM, Haythomthwaite JA, Heinberg LJ, et al. The impact of pain and symptoms of depression in scleroderma. Pain, 2002,95:267-275.
[5] Medsger TA Jr, Lucas M, Wildy KS, et al. D-penicillamine in systemic sclerosis? Yes! Scand J Rheumatol, 2001, 30:192-194.
[6] Wigley FM, Sule SD. Novel therapy in the treatment of scleroderma.Expert Opin Investig Drugs, 2001, 10:31-48.
[7] Le CH, Morales A, Trentham DE. Minocycline in early diffuse scleroderma. Lancet, 1998, 352:1755-1756.
[8] Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol, 2002, 138:99-105.
[9] Ellman MH, McDonald PA, Hayes FA,et al. Etanercept as treatment for diffuse scleroderma:a pilot study (abstact). Arthritis Rheum,2000,43:S392.
[10] Furst DE, Tyndall A. Stem cell transplantation in systemic sclerosis:rationale and status report. Isr Med Assoc J, 2000, 2:935-937.
[11] Schachna L, Wigley FM, White B, et al. Lung transplantation in scleroderma:the Johns Hopskins experience (abstact). Arthritis Rheum,2000,43:S392.
[12] Kubo M, Vensak J, Dauber J, et al. Lung transplantation in patients with scleroderma. J Heart Lung Transplant, 2001,20:174-175.
[13] Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol, 2001,26:343-350.
[14] Stege H, Bemeburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol, 1997,. 36:938-944.
[15] Morita A, Kobayashi K, Isomura I, et al. Ultraviolet Al (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol, 2000, 43:670-674.
[16] Umezawa Y. Seeing what was unseen:new analytical methods for molecular imaging. Chem Rec, 2003,3:22-28.
[17] Kress M, Meier T, Steiner R, et al. Time-resolved microspectrofluorometry and fluorescence lifetime imaging of photosensitizers using picosecond pulsed diode lasers in laser scanning microscopes. J Biomed Opt, 2003, 8:26-32.
[18] Huzaira M, Rius F, Rajadhyaksha M, et al. Topographic variations in normal skin, as viewed by in vivo reflectance confocal microscopy. J Invest Dermatol, 2001, 116:846-852.
[19] Rajadhyaksha M, Gonzalez S, Zavislan JM, et al. In vivo confocal scanning laser microscopy of human skin II:advances in instrumentation and comparison with histology. J Invest Dermatol, 1999, 113:293-303.
[20] Sanermann K, Clemann S, Jaspers S, et al. Age related changes of human skin investigated with histometric measurements by confocal laser scanning microscopy in vivo. Skin Res Technol, 2002, 8:52-56.
[21] Swindle LD, Thomas SG, Freeman M,et al. View of normal human skin in vivo as observed using fluorescent fiber-optic confocal microscopic imaging. J Invest Dermatol, 2003, 121:706-712.
[22] Charles CA, Marghoob AA, Busam KJ, et al. Melanoma or pigmented basal cell carcinoma:a clinical-pathologic correlation with dermoscopy, in vivo confocal scanning laser microscopy, and routine histology. Skin Res Technol, 2002, 8:282-287.
[23] Sauermann K, Gambichler T, Jaspers S, et al. Histometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosis. BMC Dermatol, 2002, 2:8.